June 8, 2020
Live Online Policy Forum

COVID-19 and the Right to Test

Featuring Jessica Flanigan, MA, PhD (@missjessica), Richard L. Morrill Chair in Ethics and Democratic Values, University of Richmond; Roger D. Klein, MD, JD (@RogerDKlein), FDA & Health Working Group, Federalist Society Regulatory Transparency Project; former Adviser to the Food and Drug Administration; moderated by Michael F. Cannon, JM, MA (@mfcannon), Director of Health Policy Studies, Cato Institute.
May 20, 2020
Live Online Policy Forum

Don’t Forget People Living in Pain: War on Opioids and Chronic Pain Patients during COVID-19

Featuring Andrea Trescot, MD, Anesthesiologist, Pain Specialist, and former Director of Pain Fellowship, University of Florida, Gainesville, and University of Washington, Seattle; Kate Nicholson, JD, Civil Rights Attorney and Pain Patient Advocate; Richard Lawhern, PhD, Cofounder and Director of Research, Alliance for the Treatment of Intractable Pain; moderated by Jeffrey A. Singer, MD, Senior Fellow, Cato Institute.

Cato Daily Podcast

Regime Uncertainty for Developers of Coronavirus Tests

When the FDA takes action against developers of diagnostic tests, it seems to come primarily during times when new tests are desperately needed. Will Rinehart of the Center for Growth and Opportunity discusses the problem.